GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OTCPK:BRCTF) » Definitions » Land And Improvements

BRCTF (BioArctic AB) Land And Improvements : $0.0 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is BioArctic AB Land And Improvements?

BioArctic AB's land and improvements for the quarter that ended in Mar. 2025 was $0.0 Mil.


BioArctic AB Land And Improvements Historical Data

The historical data trend for BioArctic AB's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Land And Improvements Chart

BioArctic AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioArctic AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioArctic AB Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


BioArctic AB Business Description

Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB Headlines

From GuruFocus

Q4 2021 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2025 BioArctic AB Earnings Call Transcript

By GuruFocus News 05-22-2025

Q4 2023 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2021 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Nine Months 2020 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2019 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2021 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Eisai increases the number of participants in Clarity AD study

By PRNewswire PRNewswire 02-03-2021

Q3 2022 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024